You are here
Cerebral Trauma Recovery (CereTRec) drug delivery system
Award Information
Agency: Department of Defense
Branch: Defense Health Agency
Contract: W81XWH-17-C-0221
Agency Tracking Number: H171-011-0132
Amount:
$149,824.00
Phase:
Phase I
Program:
SBIR
Solicitation Topic Code:
DHA17-011
Solicitation Number:
2017.1
Timeline
Solicitation Year:
2017
Award Year:
2017
Award Start Date (Proposal Award Date):
2017-09-25
Award End Date (Contract End Date):
2018-04-24
Small Business Information
1225 Shamrock Ave
Monrovia, CA
91016
United States
DUNS:
168312028
HUBZone Owned:
No
Woman Owned:
No
Socially and Economically Disadvantaged:
No
Principal Investigator
Name: Don Johnson
Title: Senior Scientist
Phone: (626) 381-9974
Email: jaxtelle@chromologic.com
Title: Senior Scientist
Phone: (626) 381-9974
Email: jaxtelle@chromologic.com
Business Contact
Name: Naresh Menon
Phone: (626) 381-9974
Email: nmenon@chromologic.com
Phone: (626) 381-9974
Email: nmenon@chromologic.com
Research Institution
N/A
Abstract
In order to meet the Defense Health Agencys need for addressing the prevention of secondary brain injury from moderate, severe and penetrating traumatic brain injury (TBI), ChromoLogic proposes to develop a cerebral trauma recovery (CereTRec) drug delivery system. In particular, CereTRec aims to treat TBI during prolonged field care (PFC) to stabilize casualties who sustain a moderate-severe TBI. In Phase I, ChromoLogic will develop, formulate, and test CereTRec for in vitro pre-clinical studies. In Phase II, CereTRec will be refined to be tested in large animal or non-human primate pre-clinical models of moderate-severe TBI for efficacy and drug dose.
* Information listed above is at the time of submission. *
